Page 95 - ARNM-3-2
P. 95

Advances in Radiotherapy
            & Nuclear Medicine                                             Influence of photon beam quality in radiotherapy



            and  Measurements  Reports  50 and  62,  the  total  error   A total of 90 patients – comprising 30 cases each of lung,
            in radiotherapy, encompassing activities such as target   gynecological, and prostate tumors – were selected to study
            delineation, treatment planning, dose calculation, patient   the impact of tissue inhomogeneities on dose calculation
            positioning, and treatment delivery, should remain under   in treatment planning. Each patient received treatment
            5%.  To maintain this degree of accuracy, systematic   using the three-dimensional conformal radiotherapy
               4,5
            quality assurance procedures for computerized treatment   (3DCRT) technique, facilitated by a Varian Clinac 2300CD
            planning systems (TPSs) have been established by several   linear accelerator equipped with 120 multileaf collimators
            task groups over the past decades. These recommendations   (MLCs) (Varian Medical System, Palo Alto, USA), at the
            cover areas such as anatomical and beam descriptions, dose   Maria Sklodowska-Curie National Research Institute of
            calculations, as well as data output and transfer. Nowadays,   Oncology in Warsaw, Poland. The treatment plans for lung,
            3D TPSs that utilize a range of dose calculation algorithms   gynecology, and prostate cases, represented in Figure 1A-C,
            are widely employed in radiotherapy planning. 6-9  respectively, were recalculated without incorporating
              For inhomogeneous geometries, comparing measured   beam modifiers, and ICFs were determined for each beam
            and calculated dose distributions in the presence of tissue   angle by comparing dose distributions computed with and
            inhomogeneities is essential, typically using inhomogeneity   without inhomogeneity corrections. All calculations were
            correction factors (ICFs). However, acquiring these   carried out at the isocenter.
            measurements  is  challenging  due  to  the  time  and   In  addition,  the  ICFs  for fifteen  lung  tumor  patients
            resources required. Some studies have reported findings   treated using stereotactic body radiation therapy (SBRT)
            on these measurements, 10-13  yet questions on whether ICFs   were  determined.  For  these  cases,  treatment  plans  were
            determined by one institution can be applied universally   created using 6 MV photons with a QI of 0.668 from a
            and how variations in a user’s beam quality index (QI)   Varian TrueBeam linear accelerator (equipped with a
            might influence the results remain unanswered.     120-leaf MLC) (Varian Medical System, Palo Alto, USA)
              This research aims to investigate the effects of changes   and were generated using multiple arcs (clockwise and
            in the beam QI, particularly the tissue phantom ratio   anticlockwise, with angles defined according to the Varian/
            (TPR 20,10 ) on ICFs in external beam radiation therapy   IEC scale) (manufacturer, country). An example of SBRT
            treatment plans.                                   plan is shown in Figure 1D. These SBRT plans were then
                                                               recalculated with a 6 MV flattening filter-free (FFF) photon
            2. Materials and methods                           beams employing beam quality of 0.632, and ICFs were
                                                               computed for both beam qualities. Along with the 3DCRT
            Photon energies of 6 MV and 15 MV were utilized to   cases, the ICFs for the SBRT plans were calculated at the
            evaluate the correlation between ICFs and the beam QI   isocenter.
            (TPR 20,10 ). The TPR 20,10  values varied within the following
            range:                                               To compare ICFs calculated among various beam
                                                               qualities, we conducted a statistical analysis using Origin
                20
            (TPR = 0.67 k±  *0.01)  for 6 MV, k = −3, −2, −1, 0, 1, 2, 3
                10
                20
            (TPR = 0.76 k±  *0.01)  for 15 MV, k = −3, −2, −1, 0, 1, 2, 3  A          B
                10
              For each energy level, TPR 20,10  values were collected
            from the Secondary Standard Dosimetry Laboratory at
            the Maria Sklodowska-Curie National Research Institute
                                     14
            of Oncology in Warsaw, Poland.  Subsequently, ICFs were
            determined using the Eclipse version 13.6 TPS by Varian
            Medical  Systems  (Palo  Alto,  CA)  with  the  anisotropic   C           D
            analytical algorithm.
              For every TPR 20,10  value, a separate set of percent depth
            dose (PDD) curves was generated for field sizes ranging
            from 5 × 5 to 30 × 30 cm² using Gerbi’s formula.  The same
                                                 15
            beam profiles and output factors measured for 6 MV and
            15 MV beams, corresponding to TPR 20,10  values of 0.670
            and 0.760, respectively, were applied. As Gerbi’s formula
            provides PDDs at a source-to-surface distance (SSD) of   Figure 1. The three-dimensional conformal radiotherapy and stereotactic
                                                               body radiation therapy (SBRT) treatment plans generated using Eclipse
            100 cm, these values were converted to an SSD of 90 cm   treatment planning system: (A) Lung; (B) Gynecology; (C) Prostate; and
            using Mayneord’s factor (F) before being input into the TPS.  (D) Lung SBRT plan


            Volume 3 Issue 2 (2025)                         87                             doi: 10.36922/arnm.6851
   90   91   92   93   94   95   96   97   98   99   100